COVID-19 vaccine may become available early next year: Harsh Vardhan
Three vaccine candidates are at different stages of clinical trials in the country
Bharat Biotech’s Covaxin is currently in Phase II human trials
ZyCoV-D, developed by Zydus Cadila, began phase II clinical trials on August 6
Serum Institute of India recently started an advance clinical trial of the vaccine made by the University of Oxford
Russian Direct Investment Fund works towards the distribution of Sputnik V vaccine in India
From one testing lab in the beginning, India now has 1,700 testing labs
Around 1,600 people between the age of 18 – 25 are to be enrolled for clinical trials
